Advertisement

Index by author

May 01, 1990; Volume 37,Issue 5

A

  1. Abel, M S

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

  2. Ashmun, R

    1. Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
      A Fridland, M C Connelly and R Ashmun
      Molecular Pharmacology May 1990, 37 (5) 665-670;

  3. Ashton, R A

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

  4. Aylwin, M

    1. Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
      M M White and M Aylwin
      Molecular Pharmacology May 1990, 37 (5) 720-724;

B

  1. Beer, B

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

  2. Bernaerts, R

    1. Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
      E De Clercq, R Bernaerts, A Merta and B Rosenwirth
      Molecular Pharmacology May 1990, 37 (5) 658-664;

  3. Blume, A J

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

  4. Bogucki, B D

    1. Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
      A E Rettie, B D Bogucki, I Lim and G P Meier
      Molecular Pharmacology May 1990, 37 (5) 643-651;

  5. Borislow, S

    1. Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;

  6. Brodersen, R

    1. Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
      R Brodersen, N Jørgensen, H Vorum and N Krukow
      Molecular Pharmacology May 1990, 37 (5) 704-709;

  7. Bruno, V

    1. Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;

  8. Brush, K

    1. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;

C

  1. Canonico, P L

    1. Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;

  2. Cavallaro, S

    1. Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;

  3. Chu, A

    1. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;

  4. Connelly, M C

    1. Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
      A Fridland, M C Connelly and R Ashmun
      Molecular Pharmacology May 1990, 37 (5) 665-670;

  5. Conner, D A

    1. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
      D A Conner and T E Mansour
      Molecular Pharmacology May 1990, 37 (5) 742-751;

  6. Copani, A

    1. Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;

  7. Crippen, G M

    1. Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC.
      A K Ghose and G M Crippen
      Molecular Pharmacology May 1990, 37 (5) 725-734;

D

  1. De Clercq, E

    1. Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
      E De Clercq, R Bernaerts, A Merta and B Rosenwirth
      Molecular Pharmacology May 1990, 37 (5) 658-664;

  2. Díaz-Muñoz, M

    1. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;

  3. Dirksen, R T

    1. Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;

  4. Doehmer, J

    1. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

  5. Dogra, S

    1. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

  6. Duman, R S

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

E

  1. Enyeart, J J

    1. Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;

  2. Evans, W E

    1. Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
      W E Evans and M V Relling
      Molecular Pharmacology May 1990, 37 (5) 639-642;

F

  1. Farb, D H

    1. Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 597-602;
    2. gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;

  2. Fridland, A

    1. Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
      A Fridland, M C Connelly and R Ashmun
      Molecular Pharmacology May 1990, 37 (5) 665-670;

  3. Friedberg, T

    1. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

  4. Friedman, L

    1. gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;

  5. Frusciante, M J

    1. Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
      D C Javitt, M J Frusciante and S R Zukin
      Molecular Pharmacology May 1990, 37 (5) 603-607;

  6. Fujimori, S

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

G

  1. Garrett, K M

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

  2. Ghose, A K

    1. Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC.
      A K Ghose and G M Crippen
      Molecular Pharmacology May 1990, 37 (5) 725-734;

  3. Gibbs, T T

    1. Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 597-602;
    2. gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;

  4. Gierschik, P

    1. Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;

  5. Gies, J P

    1. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
      E B Haddad, Y Landry and J P Gies
      Molecular Pharmacology May 1990, 37 (5) 682-688;

  6. Glatt, H

    1. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

H

  1. Haddad, E B

    1. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
      E B Haddad, Y Landry and J P Gies
      Molecular Pharmacology May 1990, 37 (5) 682-688;

  2. Hamilton, S L

    1. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;

  3. Haslam, R J

    1. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
      D H Maurice and R J Haslam
      Molecular Pharmacology May 1990, 37 (5) 671-681;

  4. Hawkes, M J

    1. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;

  5. He, H T

    1. Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;

  6. Hooper, W D

    1. Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
      P E Reilly, D A Thompson, S R Mason and W D Hooper
      Molecular Pharmacology May 1990, 37 (5) 767-774;

I

  1. Ivins, K J

    1. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
      K J Ivins and P B Molinoff
      Molecular Pharmacology May 1990, 37 (5) 622-630;

J

  1. Jakobs, K H

    1. Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;

  2. Javitt, D C

    1. Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
      D C Javitt, M J Frusciante and S R Zukin
      Molecular Pharmacology May 1990, 37 (5) 603-607;

  3. Jørgensen, N

    1. Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
      R Brodersen, N Jørgensen, H Vorum and N Krukow
      Molecular Pharmacology May 1990, 37 (5) 704-709;

K

  1. Krukow, N

    1. Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
      R Brodersen, N Jørgensen, H Vorum and N Krukow
      Molecular Pharmacology May 1990, 37 (5) 704-709;

L

  1. Landry, Y

    1. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
      E B Haddad, Y Landry and J P Gies
      Molecular Pharmacology May 1990, 37 (5) 682-688;

  2. Law, S F

    1. Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;

  3. Lim, I

    1. Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
      A E Rettie, B D Bogucki, I Lim and G P Meier
      Molecular Pharmacology May 1990, 37 (5) 643-651;

M

  1. Magnan, J

    1. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
      M Tiberi and J Magnan
      Molecular Pharmacology May 1990, 37 (5) 694-703;

  2. Manning, D

    1. Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;

  3. Mansour, T E

    1. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
      D A Conner and T E Mansour
      Molecular Pharmacology May 1990, 37 (5) 742-751;

  4. Martin, J M

    1. Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;

  5. Mason, S R

    1. Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
      P E Reilly, D A Thompson, S R Mason and W D Hooper
      Molecular Pharmacology May 1990, 37 (5) 767-774;

  6. Maurice, D H

    1. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
      D H Maurice and R J Haslam
      Molecular Pharmacology May 1990, 37 (5) 671-681;

  7. Meier, G P

    1. Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
      A E Rettie, B D Bogucki, I Lim and G P Meier
      Molecular Pharmacology May 1990, 37 (5) 643-651;

  8. Merta, A

    1. Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
      E De Clercq, R Bernaerts, A Merta and B Rosenwirth
      Molecular Pharmacology May 1990, 37 (5) 658-664;

  9. Mölders, H

    1. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

  10. Molinoff, P B

    1. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
      K J Ivins and P B Molinoff
      Molecular Pharmacology May 1990, 37 (5) 622-630;

  11. Müller, U

    1. Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;

N

  1. Nicoletti, F

    1. Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;

O

  1. Oesch, F

    1. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

R

  1. Reilly, P E

    1. Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
      P E Reilly, D A Thompson, S R Mason and W D Hooper
      Molecular Pharmacology May 1990, 37 (5) 767-774;

  2. Reisine, T

    1. Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;

  3. Reithmann, C

    1. Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;

  4. Relling, M V

    1. Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
      W E Evans and M V Relling
      Molecular Pharmacology May 1990, 37 (5) 639-642;

  5. Rens-Domiano, S

    1. Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;

  6. Rettie, A E

    1. Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
      A E Rettie, B D Bogucki, I Lim and G P Meier
      Molecular Pharmacology May 1990, 37 (5) 643-651;

  7. Roca, D J

    1. gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;

  8. Rosenwirth, B

    1. Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
      E De Clercq, R Bernaerts, A Merta and B Rosenwirth
      Molecular Pharmacology May 1990, 37 (5) 658-664;

  9. Rozenberg, I

    1. gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;

S

  1. Saito, N

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

  2. Schiller, G D

    1. gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;

  3. Schonbrunn, A

    1. Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function.
      S L Swope and A Schonbrunn
      Molecular Pharmacology May 1990, 37 (5) 758-766;

  4. Seidel, A

    1. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

  5. Sharma, V K

    1. Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;

  6. Sheu, S S

    1. Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;

  7. Siegert, P

    1. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

  8. Sortino, M A

    1. Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;

  9. Swope, S L

    1. Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function.
      S L Swope and A Schonbrunn
      Molecular Pharmacology May 1990, 37 (5) 758-766;

T

  1. Tallman, J F

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

  2. Thompson, D A

    1. Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
      P E Reilly, D A Thompson, S R Mason and W D Hooper
      Molecular Pharmacology May 1990, 37 (5) 767-774;

  3. Tiberi, M

    1. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
      M Tiberi and J Magnan
      Molecular Pharmacology May 1990, 37 (5) 694-703;

V

  1. Vitek, M P

    1. Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

  2. Vorum, H

    1. Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
      R Brodersen, N Jørgensen, H Vorum and N Krukow
      Molecular Pharmacology May 1990, 37 (5) 704-709;

W

  1. Werdan, K

    1. Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;

  2. White, M M

    1. Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
      M M White and M Aylwin
      Molecular Pharmacology May 1990, 37 (5) 720-724;

  3. Williford, D J

    1. Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;

  4. Woolkalis, M

    1. Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;

  5. Wu, F S

    1. Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 597-602;

Z

  1. Zukin, S R

    1. Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
      D C Javitt, M J Frusciante and S R Zukin
      Molecular Pharmacology May 1990, 37 (5) 603-607;
Back to top

In this issue

Advertisement